Literature DB >> 7575228

The relationship of neuropsychological functioning to quality of life in epilepsy.

K Perrine1, B P Hermann, K J Meador, B G Vickrey, J A Cramer, R D Hays, O Devinsky.   

Abstract

OBJECTIVE: To examine the relationship of objectively assessed cognitive functioning to self-reported quality of life.
DESIGN: Correlational, multiple regression, and factor analytic comparisons of a new self-report quality of life inventory with neuropsychological tests of cognition and mood.
SUBJECTS: Two hundred fifty-seven patients with epilepsy.
SETTING: Twenty-five epilepsy centers and neurology clinics across the United States. MEASURES: A recently developed self-report (ie, Quality of Life in Epilepsy-89 inventory) and objective tests of memory, verbal abilities, spatial functions, psychomotor and cognitive processing speed, cognitive flexibility, and mood.
RESULTS: Factors that assessed mood, psychomotor speed, verbal memory, and language correlated significantly with selected scales of the Quality of Life in Epilepsy-89 inventory (P < .0001) and were predictive of overall quality of life (P < .002 to P < .0001). The mood factor showed the highest correlations (r = -.20 to r = -.73) and was the strongest predictor of quality of life in regression analyses (46.7% explained variance, P < .0001).
CONCLUSIONS: Mood may be adversely affected by diminished quality of life, or perceived quality of life may be affected by mood disturbance. Quantitative quality of life assessments can be used in conjunction with formal neuropsychological testing of mood and cognition when evaluating patients with epilepsy.

Entities:  

Mesh:

Year:  1995        PMID: 7575228     DOI: 10.1001/archneur.1995.00540340089017

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  42 in total

1.  Depression in Epilepsy Is Much More Than a Reactive Process.

Authors:  Andres M. Kanner
Journal:  Epilepsy Curr       Date:  2003-11       Impact factor: 7.500

Review 2.  Current Concepts of Memory Disorder in Epilepsy: Edging Towards a Network Account.

Authors:  Genevieve Rayner; Chris Tailby
Journal:  Curr Neurol Neurosci Rep       Date:  2017-08       Impact factor: 5.081

3.  Depression in epilepsy: mechanisms and therapeutic approach.

Authors:  Marco Mula; Bettina Schmitz
Journal:  Ther Adv Neurol Disord       Date:  2009-09       Impact factor: 6.570

Review 4.  Health-related quality of life in youth with epilepsy: theoretical model for clinicians and researchers. Part I: the role of epilepsy and co-morbidity.

Authors:  Lucyna M Lach; Gabriel M Ronen; Peter L Rosenbaum; Charles Cunningham; Michael H Boyle; Shauna Bowman; David L Streiner
Journal:  Qual Life Res       Date:  2006-09-13       Impact factor: 4.147

5.  Use of preoperative functional MRI to predict verbal memory decline after temporal lobe epilepsy surgery.

Authors:  Jeffrey R Binder; David S Sabsevitz; Sara J Swanson; Thomas A Hammeke; Manoj Raghavan; Wade M Mueller
Journal:  Epilepsia       Date:  2008-04-24       Impact factor: 5.864

6.  Risks of suicidality in adult patients with epilepsy.

Authors:  Sherifa A Hamed; Yaser Be Elserogy; Madleen A Abdou; Mostafa M Abdellah
Journal:  World J Psychiatry       Date:  2012-04-22

Review 7.  Anterior temporal lobectomy, hippocampal sclerosis, and memory: recent neuropsychological findings.

Authors:  B D Bell; K G Davies
Journal:  Neuropsychol Rev       Date:  1998-03       Impact factor: 7.444

Review 8.  Epilepsy, depression, and growth hormone.

Authors:  Tracy Butler; Patrick Harvey; Lila Cardozo; Yuan-Shan Zhu; Adam Mosa; Emily Tanzi; Fahad Pervez
Journal:  Epilepsy Behav       Date:  2019-02-14       Impact factor: 2.937

Review 9.  Depression and epilepsy: do glucocorticoids and glutamate explain their relationship?

Authors:  Andres M Kanner
Journal:  Curr Neurol Neurosci Rep       Date:  2009-07       Impact factor: 5.081

10.  Quality of life in childhood epilepsy with lateralized epileptogenic foci.

Authors:  Krystyna A Mathiak; Małgorzata Luba; Klaus Mathiak; Katarzyna Karzel; Tomasz Wolańczyk; Elzbieta Szczepanik; Paweł Ostaszewski
Journal:  BMC Neurol       Date:  2010-08-17       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.